Rafael C. Rosell
Expertise in
13
conditions

Rafael C. Rosell

Instituto Oncológico Dr Rosell, 
Barcelona, CT, ES 
Expertise in
13
conditions
Instituto Oncológico Dr Rosell, 
Barcelona, CT, ES 

Overview

Rafael Rosell practices practicing medicine in Barcelona, Spain.

Mr. Rosell is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Tissue Biopsy, and Adenoidectomy.

He is actively involved in clinical research, co-authoring 424 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Instituto Oncológico Dr Rosell, Barcelona, CT, Spain
Other Locations
Badalona, CT, Spain
Cerdanyola Del Valles, CT, Spain
Frias, CL, Spain
Bellaterra, CT, Spain
Department Of Otorhinolaryngology Head And Neck Surgery, Sabadell, CT, Spain
Instituto Oncológico Dr Rosell, 1. 08195 Sant Cugat Del Vallès, Sant Cugat Del Valles, CT 08195, Spain
A Coruna, GA, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Drug
Study Drugs: Aldoxorubicin, Topotecan
Study Phase: Phase 2

423 Total Publications

Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report.
Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 15, 2026

Frequently Asked Questions about Rafael C. Rosell

Is Rafael C. Rosell a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Rafael C. Rosell is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rafael C. Rosell participate in research or clinical trials?

Yes. Rafael C. Rosell has published 423 articles and abstracts on conditions like Lung Cancer. You can view a list of Rafael C. Rosell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rosell's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile